Completed PHASE3 INTERVENTIONAL 2-arm NCT04537078

Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

Sponsor: El Shatby University Hospital for Obstetrics and Gynecology

Interventions Cetrotide Injectable Product Chorionic Gonadotropin Combined Oral Contraceptive Cyclo-Progynova Decapeptyl Duphaston Gonadotropin progesterone

Updated 5 times since 2020 Last updated: Jan 26, 2022 Started: Sep 1, 2020 Primary completion: Mar 1, 2021 Completion: Sep 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Infertility, Female, this trial is completed. The trial is conducted by El Shatby University Hospital for Obstetrics and Gynecology and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2022 — Jul 2024 [monthly]

Completed PHASE3

Status: Not Yet Recruiting → Completed
Jan 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE3
Oct 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

El Shatby University Hospital for Obstetrics and Gynecology

Data source: El Shatby University Hospital for Obstetrics and Gynecology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt